# Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes

> **NCT00223067** · PHASE1 · UNKNOWN · sponsor: **University Hospital Schleswig-Holstein** · enrollment: 10 (—)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** TAIZ

## Key facts

- **NCT ID:** NCT00223067
- **Lead sponsor:** University Hospital Schleswig-Holstein
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 10 (—)
- **Last updated:** 2005-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00223067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00223067, "Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00223067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*